97 related articles for article (PubMed ID: 31823639)
1. Elevated high mobility group A2 expression in liver cancer predicts poor patient survival.
Zhao YC; Jiao Y; Li YQ; Fu Z; Yang ZY; He M
Rev Esp Enferm Dig; 2020 Jan; 112(1):27-33. PubMed ID: 31823639
[TBL] [Abstract][Full Text] [Related]
2. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
3. High Trophinin-Associated Protein Expression Is an Independent Predictor of Poor Survival in Liver Cancer.
Jiao Y; Li Y; Lu Z; Liu Y
Dig Dis Sci; 2019 Jan; 64(1):137-143. PubMed ID: 30284652
[TBL] [Abstract][Full Text] [Related]
4. RNA-binding protein insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor invasion and predicts early recurrence and poor prognosis in hepatocellular carcinoma.
Jeng YM; Chang CC; Hu FC; Chou HY; Kao HL; Wang TH; Hsu HC
Hepatology; 2008 Oct; 48(4):1118-27. PubMed ID: 18802962
[TBL] [Abstract][Full Text] [Related]
5. Increased high-mobility group A2 correlates with lymph node metastasis and prognosis of non-small cell lung cancer.
Guo X; Shi J; Wen Y; Li M; Li Q; Li X; Li J
Cancer Biomark; 2018 Feb; 21(3):547-555. PubMed ID: 29278873
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of high-mobility group A2: A novel independent indicator of poor prognosis in patients with esophageal squamous cell carcinoma.
Wei R; Shang Z; Leng J; Cui L
J Cancer Res Ther; 2016; 12(4):1291-1297. PubMed ID: 28169242
[TBL] [Abstract][Full Text] [Related]
7. P300-dependent acetylation of histone H3 is required for epidermal growth factor receptor-mediated high-mobility group protein A2 transcription in hepatocellular carcinoma.
Liang C; Niu J; Wang X; Zhang ZS; Yang RH; Yao X; Liu FY; Li WQ; Pei SH; Sun H; Wang CJ; Fang D; Xie SQ
Cancer Sci; 2021 Feb; 112(2):679-690. PubMed ID: 33164305
[TBL] [Abstract][Full Text] [Related]
8. Clinical Significance of TRMT6 in Hepatocellular Carcinoma: A Bioinformatics-Based Study.
Wang Y; Huang Q; Deng T; Li BH; Ren XQ
Med Sci Monit; 2019 May; 25():3894-3901. PubMed ID: 31128068
[TBL] [Abstract][Full Text] [Related]
9. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
[TBL] [Abstract][Full Text] [Related]
10. Expression Pattern and Clinical Significance of Gab2 Protein in Hepatocellular Carcinoma.
Hu X; He B; Zhou L; Xie H; Zheng S
Clin Lab; 2016; 62(6):1087-92. PubMed ID: 27544933
[TBL] [Abstract][Full Text] [Related]
11. High expression of Anxa2 and Stat3 promote progression of hepatocellular carcinoma and predict poor prognosis.
Tang L; Liu JX; Zhang ZJ; Xu CZ; Zhang XN; Huang WR; Zhou DH; Wang RR; Chen XD; Xiao MB; Qu LS; Lu CH
Pathol Res Pract; 2019 Jun; 215(6):152386. PubMed ID: 30935762
[TBL] [Abstract][Full Text] [Related]
12. Low expression of CD112 is associated with poor overall survival in patients with hepatocellular carcinoma.
Huang X; Qu P; Chen Y; Zhou X; Wu Y; Liu F; Wang D; Zhang J; An J
Hum Pathol; 2014 Sep; 45(9):1944-50. PubMed ID: 25081539
[TBL] [Abstract][Full Text] [Related]
13. Elevated expression of UHRF1 predicts unfavorable prognosis for patients with hepatocellular carcinoma.
Liang D; Xue H; Yu Y; Lv F; You W; Zhang B
Int J Clin Exp Pathol; 2015; 8(8):9416-21. PubMed ID: 26464697
[TBL] [Abstract][Full Text] [Related]
14. Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.
Meguro M; Mizuguchi T; Nishidate T; Okita K; Ishii M; Ota S; Ueki T; Akizuki E; Hirata K
World J Gastroenterol; 2015 Apr; 21(16):4933-45. PubMed ID: 25945007
[TBL] [Abstract][Full Text] [Related]
15. Mastermind-like Transcriptional Coactivator 1 Overexpression Predicts Poor Prognosis in Human with Hepatocellular Carcinoma.
Wang J; Zhang SM; Wu JM; Lu ZC; Yang JR; Wu HS; Chen H; Lin B; Xu RH; Cao TS
Ann Clin Lab Sci; 2016 Sep; 46(5):502-7. PubMed ID: 27650617
[TBL] [Abstract][Full Text] [Related]
16. The effects of the location of cancer stem cell marker CD133 on the prognosis of hepatocellular carcinoma patients.
Chen YL; Lin PY; Ming YZ; Huang WC; Chen RF; Chen PM; Chu PY
BMC Cancer; 2017 Jul; 17(1):474. PubMed ID: 28687090
[TBL] [Abstract][Full Text] [Related]
17. Expression and prognostic significance of vascular endothelial growth factor receptor 1 in hepatocellular carcinoma.
Li T; Zhu Y; Qin CY; Yang Z; Fang A; Xu S; Ren W
J Clin Pathol; 2012 Sep; 65(9):808-14. PubMed ID: 22734007
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value of combined TGF-β1 and ELF in hepatocellular carcinoma.
Ji F; Fu SJ; Shen SL; Zhang LJ; Cao QH; Li SQ; Peng BG; Liang LJ; Hua YP
BMC Cancer; 2015 Mar; 15():116. PubMed ID: 25880619
[TBL] [Abstract][Full Text] [Related]
19. Expression of high mobility group A2 is associated with poor survival in hepatocellular carcinoma.
Wu L; Wang Z; Lu R; Jiang W
Pathol Oncol Res; 2012 Oct; 18(4):983-7. PubMed ID: 22461106
[No Abstract] [Full Text] [Related]
20. High-mobility group protein box1 expression correlates with peritumoral macrophage infiltration and unfavorable prognosis in patients with hepatocellular carcinoma and cirrhosis.
Zhang QB; Jia QA; Wang H; Hu CX; Sun D; Jiang RD; Zhang ZL
BMC Cancer; 2016 Nov; 16(1):880. PubMed ID: 27836008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]